Camden, NJNCT06510582Now EnrollingIRB Ready

Chronic Subdural Hematoma Clinical Trial in Camden, NJ

Access cutting-edge chronic subdural hematoma treatment through this clinical trial at a research site in Camden. Study-provided care at no cost to qualified participants.

Sponsored by The Cooper Health System

Quick Self-Assessment

See if you qualify for this Camden location

Preparing your pre-screening questions…

Expert Care in Camden

Access chronic subdural hematoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic subdural hematoma treatment provided free

Apply for This Camden Location

Check if you qualify for this chronic subdural hematoma clinical trial in Camden, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Camden

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Camden site if eligible
  4. 4Begin participation

About This Chronic Subdural Hematoma Study in Camden

The goal of this clinical trial is to test whether infusing bevacizumab into the middle meningeal arteries can be used to treat chronic subdural hematomas (cSDH). The main questions it aims to answer are: * Is bevacizumab infusion safe in cSDH patients? * Is bevacizumab infusion effective in treating cSDH?

Sponsor: The Cooper Health System

Who Can Participate

Inclusion Criteria

Adult patients (≥18 years)
Radiographic evidence of chronic subdural hematoma, including
Persistence of subdural blood more than 10 days after index traumatic injury or event
Presence of mixed density blood
Presence of subdural membranes
Can obtain informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization.

Exclusion Criteria

Pregnant, breastfeeding, or unwilling to practice contraception during participation in the study.
Patients with concomitant intracranial pathology other than subdural hematoma (e.g., intracranial malignancy).
Patients with known hypersensitivity to bevacizumab.
Patients with radiographic evidence of mass effect.
Patients have focal neurological deficits attributed to subdural hematoma.
Patient had craniotomy or burr hole operative procedures performed in preceding two weeks prior to onset of subdural hematoma.
Secondary causes apart from trauma for the chronic subdural hematoma, such as underlying vascular abnormality or tumor.
Emergent surgical evacuation is required for the patient.
Non-convexity chronic subdural hematoma, as the middle meningeal artery will not supply this area.
Coagulation abnormalities, including platelet count \<100,000 and/or international normalized ratio of \<1.5 despite attempts for correction.
Patients with known contraindications for angiography. Patients with contrast allergy will be premedicated with diphenhydramine and steroids.
Patient has known active systemic infection or sepsis.
Patient has contradiction to anesthetic agents used for conscious sedation/monitored anesthesia care (MAC).
Patient has life expectancy of less than six months due to comorbid terminal conditions.
Patient has a premorbid modified Rankin score (mRS) of 5 or greater.
Concurrent participation in another research protocol for investigation of an experimental therapy.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Camden?

Yes, this clinical trial (NCT06510582) has an active research site in Camden, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Subdural Hematoma Treatment Options in Camden, NJ

If you're searching for chronic subdural hematoma treatment options in Camden, NJ, this clinical trial (NCT06510582) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Camden research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic subdural hematoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic subdural hematoma clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Camden, NJ

See all rheumatoid arthritis clinical trials recruiting in Camden — not just this study.

Browse Rheumatoid Arthritis Trials in Camden →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Camden?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Camden, NJ